000 01180 a2200325 4500
005 20250514185940.0
264 0 _c20050208
008 200502s 0 0 eng d
022 _a0303-7207
024 7 _a10.1016/j.mce.2003.10.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarthwaite, Susan M
245 0 0 _aThe evolution of aldosterone antagonists.
_h[electronic resource]
260 _bMolecular and cellular endocrinology
_cMar 2004
300 _a27-31 p.
_bdigital
500 _aPublication Type: Historical Article; Journal Article
650 0 4 _aAldosterone
_xhistory
650 0 4 _aAnimals
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aEplerenone
650 0 4 _aGynecomastia
_xdrug therapy
650 0 4 _aHistory, 20th Century
650 0 4 _aHumans
650 0 4 _aMineralocorticoid Receptor Antagonists
_xchemical synthesis
650 0 4 _aSpironolactone
_xanalogs & derivatives
700 1 _aMcMahon, Ellen G
773 0 _tMolecular and cellular endocrinology
_gvol. 217
_gno. 1-2
_gp. 27-31
856 4 0 _uhttps://doi.org/10.1016/j.mce.2003.10.005
_zAvailable from publisher's website
999 _c14844377
_d14844377